Jim Uppal

Doctor of Osteopathic Medicine,  Cleveland Clinic 

Location: Africa

Consulting Services

Scientific Writing Research Consulting Career Advice and Mentoring

Areas Of Interest

Trophoblastic Diseases, Gestational Epithelial Neoplasms, Glandular meso-Dimercaptosuccinic Acid Detection, Psychological Signal scapularis, Ixodes Antishock Trousers, Military cAMP Phosphodiesterase 7 Cycloviruses Rhesus Blood-Group Systems Remission, Spontaneous Neoplasm Lipectomies, Aspiration Salmonella enterica serovar enteritidis Brainstem Ischemia, Transient Figural Aftereffects Pharmaceutic Technology Drugs, Hallucinogenic Cleavage And Polyadenylation Specificity Factor v-Ha-ras Oncogene Kwells Sublingual Administrations Persian Gulf Artery Stenosis, Coronary Cytoplasmic Membranes Umbellularia Proteins, Retinoic Acid-Binding Deoxycholate, Glycine Cytophagaceae Syndrome, Shy-Magee Interleukin-4 Receptors alpha Proteins, Dietary Egg Pax Transcription Factors

Professional Narrative

Dr. Jim Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 2013
Senior Director, Amgen 1999

Education

Bachelor of science in nursing, Weill Medical College 1994
Doctor of osteopathic medicine, Baylor College 1994

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :